As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

Stay up to date on the latest AI technology advancements and learn about the challenges and opportunities AI presents now and ...

SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...